ATE128626T1 - Verwendung von c63-amidderivaten von 34- de(acetylglucosaminyl)-34-deoxy-teicoplanin gegen glykopeptid-antibiotika resistente bakterien. - Google Patents

Verwendung von c63-amidderivaten von 34- de(acetylglucosaminyl)-34-deoxy-teicoplanin gegen glykopeptid-antibiotika resistente bakterien.

Info

Publication number: ATE128626T1
Authority: AT; Austria
Prior art keywords: acetylglucosaminyl; deoxy; amide derivatives; resistant bacteria; antibiotic resistant
Prior art date: 1990-05-28

Application number

AT91108165T

Other languages

English (en)

Inventor

Adriano Malabarba

Juergen Kurt Kettenring

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-28

Filing date

1991-05-21

Publication date

1995-10-15

1991-05-21 Application filed by Lepetit Spa filed Critical Lepetit Spa

1995-10-15 Application granted granted Critical

1995-10-15 Publication of ATE128626T1 publication Critical patent/ATE128626T1/de

Links

150000001408 amides Chemical class 0.000 title abstract 3
241000894006 Bacteria Species 0.000 title abstract 2
239000003910 polypeptide antibiotic agent Substances 0.000 title abstract 2
229960001608 teicoplanin Drugs 0.000 title abstract 2
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 title 1
150000002148 esters Chemical class 0.000 abstract 2
RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 abstract 1
241001505901 Streptococcus sp. 'group A' Species 0.000 abstract 1
-1 acetylglucosaminyl Chemical group 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
229920000768 polyamine Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G23/00—Compounds of titanium
- C01G23/04—Oxides; Hydroxides
- C01G23/047—Titanium dioxide
- C01G23/053—Producing by wet processes, e.g. hydrolysing titanium salts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/06—Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G23/00—Compounds of titanium
- C01G23/04—Oxides; Hydroxides
- C01G23/047—Titanium dioxide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Geology (AREA)
Nanotechnology (AREA)
Crystallography & Structural Chemistry (AREA)
Inorganic Chemistry (AREA)
General Life Sciences & Earth Sciences (AREA)
Environmental & Geological Engineering (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Materials Engineering (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Immunology (AREA)
Manufacturing & Machinery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT91108165T 1990-05-28 1991-05-21 Verwendung von c63-amidderivaten von 34- de(acetylglucosaminyl)-34-deoxy-teicoplanin gegen glykopeptid-antibiotika resistente bakterien. ATE128626T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90110102		1990-05-28

Publications (1)

Publication Number	Publication Date
ATE128626T1 true ATE128626T1 (de)	1995-10-15

Family

ID=8204033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91108165T ATE128626T1 (de)	1990-05-28	1991-05-21	Verwendung von c63-amidderivaten von 34- de(acetylglucosaminyl)-34-deoxy-teicoplanin gegen glykopeptid-antibiotika resistente bakterien.

Country Status (10)

Country	Link
EP (1)	EP0460448B1 (de)
JP (1)	JPH04235187A (de)
KR (1)	KR910019628A (de)
AT (1)	ATE128626T1 (de)
AU (1)	AU647122B2 (de)
DE (1)	DE69113513T2 (de)
DK (1)	DK0460448T3 (de)
IE (1)	IE72144B1 (de)
IL (1)	IL98211A (de)
ZA (1)	ZA913987B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4304716A1 (de) *	1993-02-16	1994-08-18	Melzer Wolfgang	Lokal applizierbares Arzneimittel mit verzögerter Freisetzung
US6392012B1 (en)	1998-12-23	2002-05-21	Advanced Medicine, Inc.	Glycopeptide derivatives and pharmaceutical compositions containing the same
KR100891014B1 (ko) *	2007-07-06	2009-04-03	대한민국	특이 항원의 면역 반응을 이용한 반코마이신 내성엔테로코커스의 감염 진단 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8704847D0 (en) *	1987-03-02	1987-04-08	Lepetit Spa	Substituted alkylamides of teicoplanin compounds
DE68925806T2 (de) *	1988-12-27	1996-09-26	Lepetit Spa	C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen

1991
- 1991-05-20 AU AU77203/91A patent/AU647122B2/en not_active Ceased
- 1991-05-21 DE DE69113513T patent/DE69113513T2/de not_active Expired - Fee Related
- 1991-05-21 AT AT91108165T patent/ATE128626T1/de not_active IP Right Cessation
- 1991-05-21 DK DK91108165.1T patent/DK0460448T3/da active
- 1991-05-21 EP EP91108165A patent/EP0460448B1/de not_active Expired - Lifetime
- 1991-05-22 IL IL9821191A patent/IL98211A/en active IP Right Grant
- 1991-05-24 JP JP3148092A patent/JPH04235187A/ja active Pending
- 1991-05-27 IE IE179891A patent/IE72144B1/en not_active IP Right Cessation
- 1991-05-27 KR KR1019910008655A patent/KR910019628A/ko not_active Ceased
- 1991-05-27 ZA ZA913987A patent/ZA913987B/xx unknown

Also Published As

Publication number	Publication date
ZA913987B (en)	1992-04-29
EP0460448A2 (de)	1991-12-11
AU7720391A (en)	1991-11-28
AU647122B2 (en)	1994-03-17
DK0460448T3 (da)	1995-11-20
EP0460448A3 (en)	1992-04-29
IE911798A1 (en)	1991-12-04
IL98211A (en)	1996-10-16
KR910019628A (ko)	1991-12-19
JPH04235187A (ja)	1992-08-24
IE72144B1 (en)	1997-03-26
DE69113513T2 (de)	1996-03-28
IL98211A0 (en)	1992-06-21
EP0460448B1 (de)	1995-10-04
DE69113513D1 (de)	1995-11-09

Legal Events

Date	Code	Title	Description
1996-03-15	UEP	Publication of translation of european patent specification
1999-02-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
MY106399A (en)	1995-05-30	Cephalosporins and homologeus, preparation and pharmaceutical composition
FI913169A0 (fi)	1991-06-28	Oligonukleotidanaloger med terminala 3'-3'- eller 5'-5'-internukleotidkopplingar.
TR199900733T2 (xx)	1999-07-21	Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlar�n tedavisi i�in bir ilac�n imalat�nda mupirosin kullan�m�.
DE3682860D1 (de)	1992-01-23	Amide von teicoplaninderivaten.
ATE68015T1 (de)	1991-10-15	Herstellung von mikrobieller zellulose.
FI931079A0 (fi)	1993-03-10	Mikrobmotverkande karbapenemderivat, deras framstaellning och terapeutiska anvaendning
DE69113513D1 (de)	1995-11-09	Verwendung von C63-Amidderivaten von 34-de(Acetylglucosaminyl)-34-deoxy-teicoplanin gegen Glykopeptid-Antibiotika resistente Bakterien.
MY111439A (en)	2000-05-31	Thymosin alpha 1 derivatives
DE59105850D1 (de)	1995-08-03	Mikrobiologisches Verfahren zur Herstellung von hydroxylierten Heterocyclen.
AU563466B2 (en)	1987-07-09	Antibiotic a 51568 factors a and b
RU93057961A (ru)	1996-05-10	Способ ферментации на плотных культуральных средах и продукт
ATE73789T1 (de)	1992-04-15	Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
ATE186328T1 (de)	1999-11-15	Mikrobiologisches verfahren zur herstellung von heteroaromatischen carbonsäuren mittels mikroorganismen der gattung alcaligenes
ATE144553T1 (de)	1996-11-15	Antibiotika ab-023 und deren herstellung
DE69012942D1 (de)	1994-11-03	Glycopeptid-Antibiotika.
FI841240A0 (fi)	1984-03-28	Foerbaettringar i makrolidantibiotika.
RU93011601A (ru)	1996-03-10	Штамм актиномицета streptomyces cattleya n11-27-продуцент тиенамицина
IT9021155A0 (it)	1990-08-01	"procedimento di desolforazione microbiologica del carbone"
SE7901094L (sv)	1979-08-15	Nya antibiotika och framstellning och anvendning derav
RU94026304A (ru)	1997-05-27	Питательная среда для культивирования анаэробов
NO963216L (no)	1996-10-01	Kondensasjons- og addisjonspolymerer med N,N'-brodannede bis-tetrametylpiperidinyloksygrupper